Oncogene Cancer Research joins 23andMe to Launch Lung Cancer Genetics Study to Advance Research

Monday 5 August, 2024
Study aims to build a comprehensive, open-source database of heritable genetics and patient-reported data in lung cancer
LONDON, 5 AUGUST 2024 – Oncogene Cancer Research, in collaboration with 23andMe Holding Co., a leading genetic health and biopharmaceutical company, and 20 lung cancer advocacy organizations…
Read More